Leukemia

FIS-HAM Salvage Therapy Effective Despite Toxicity

Published in Cancer Weekly, August 21st, 2001

by Michael Greer, senior medical writer - A chemotherapy salvage regimen consisting of fludarabine, cytosine arabinoside, and mitoxantrone (FIS-HAM) is an effective treatment for advanced leukemia, despite its high toxicity, researchers in Germany report.

"Patients with refractory acute leukemias after intensive induction and salvage attempts have a particularly poor prognosis and therapeutic options are limited," according to Wolfgang Kern and colleagues at the University of Munich, Carl Gustav Carus University in Dresden, Georg August University in Gottingen, Westfalische Wilhelms University in Munster, and Braunschweig's City Hospital.

The FIS-HAM...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-08-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry